ArticleBlood advances2022

Development of BRAFV600E-positive acute myeloid leukemia in a patient on long-term dabrafenib for multisystem LCH.

Marta Salek et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.